52w high/low | ₹730 / ₹374 |
P/E ratio | 12 |
Dividend | 0.8 |
ROE | 16.59 |
ROCE | 21.31 |
Face value | 10 |
Book value | ₹723.71Cr |
Market capital | ₹822.9Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Incorporated in 1938 at Calcutta, Albert David (ADL) is headed by Chairman A K Kothari. Its units at Calcutta, Ghaziabad and Raisin manufacture pharmaceutical formulations, including amino acid infusions. The company also manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers. ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug. '87. It has also set up a new unit in Kalyani, West Bengal, to manufacture bulk drugs, which went on stream in 1990. Another rights issue in Mar.